 | Study AZ3110866: A fixed dose study of SB-742457 versus placebo when added to existing Donepezil treatment in subjects with mild-to-moderate Alzheimer's disease, 2008 - 2009
Funded by: Glaxo Smith Kline Australia Pty Ltd |
| An efficacy study of a cognitive-communicative intervention to improve transition to residential care in dementia., 2008 - 2011
Funded by: National Health And Medical Research Council |
| Double-Blind, Parallel-Group Comparison of 23mg Donepezil Sustained Release to 10mg Donepezil Immediate Release in Patients with Moderate to Severe Alzheimer's Disease, 2007 - 2009
Funded by: ICON Clinical Research Pty Limited |
| Clinical outcomes, staff and carer perceptions of acute hospitalisation of patients with dementia, 2008 - 2011
Funded by: National Health And Medical Research Council |
| Validation of a competency assessment method for persons with dementia, 2009 - 2011
Funded by: National Health And Medical Research Council |
| Synaptic dysfunction in Alzheimer's Disease, 2007 - 2010
Funded by: Alzheimer's Association (Chicago) |
| Enhancing transition from home to residential care in dementia, 2007 - 2010
Funded by: The JO and JR Wicking Trust |
| Prospective study of the emergence of syndromal and sub-syndromal anxiety and depression during cognitive decline., 2007 - 2010
Funded by: National Health And Medical Research Council |
| Validation of Cognitive Assessments using Telecommunication, 2007 - 2009
Funded by: National Health and Medical Research Council |
| Efficacy of agomelatine (25 to 50mg/day) given orally on quality remission in elderly depressed patients after a 12-week treatment period. A randomised, double-blind, flexible dose, international...., 2006 - 2006
Funded by: Servier |
| Implicit learning and cognitive communicative interventions in Alzheimer's disease, 2006 - 2007
Funded by: University of Queensland |
| Alzheimer's Disease Research Centre, 2006 - 2009
Funded by: Royal Brisbane & Women'S Hospital Foundation |
| Cogni-screen, 2004 - 2005
Funded by: Telstra |
| A prospective study of incident neuropsychiatric symptoms in late onset Alzheimer's diseas, 2004 - 2004
Funded by: University Of Queensland |
| A randomized, multicenter, double-blind, placebo-controlled, 18 month study of the efficacy of xaliproden in patients with mild to moderate dementia of the Alzheimer's type. Protocol No. EFC 2724., 2003 - 2008
Funded by: Sanofi - Synthelabo Australia Pty Ltd |
| How well do health and community services help older people with neurodegenerative disorders and their family caregivers?, 2003 - 2005
Funded by: National Health and Medical Research Council |
| Page: | 1 |
| |
| Select all records |
| |
